Yüklüyor......

Ibrutinib in association with venetoclax for the treatment of mantle-cell lymphoma: a multicenter case series

Introduction: Mantle-cell lymphoma (MCL) with relapsed/refractory (R/R) disease after intensive chemotherapy have few effective treatment options. Ibrutinib showed a promising median progression-free survival (PFS) with manageable toxicity. The BCL2 inhibitor venetoclax showed encouraging results in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Blood Res
Asıl Yazarlar: Fabbri, Alberto, Cencini, Emanuele, Congiu, Angela Giovanna, Miglino, Maurizio, Rigacci, Luigi, Bocchia, Monica
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: e-Century Publishing Corporation 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7811909/
https://ncbi.nlm.nih.gov/pubmed/33489445
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!